In recent weeks, global markets have been buoyed by expectations of a "red sweep" in the U.S., with major indices like the S&P 500 and Nasdaq Composite reaching record highs as investors anticipate favorable growth and tax policies. Amid this optimism, identifying growth companies with significant insider ownership can offer insights into businesses where those closest to the operations have strong confidence in their future potential.
Top 10 Growth Companies With High Insider Ownership
Overview: Odas Elektrik Üretim Sanayi Ticaret A.S., along with its subsidiaries, is involved in the production and sale of electricity through natural gas combined cycles both in Turkey and internationally, with a market cap of TRY8.61 billion.
Operations: The company generates revenue of TRY6.71 billion from Uzbekistan and incurs a negative revenue of TRY1.54 billion in the Republic of Turkey.
Insider Ownership: 21.5%
Odas Elektrik Üretim Sanayi Ticaret is forecasted to experience significant revenue growth at 32% annually, outpacing the Turkish market's average of 25.5%. Despite recent financial setbacks, including a TRY 2.34 billion net loss in Q2 2024, the company is expected to become profitable within three years. Currently trading at a substantial discount to its estimated fair value, Odas offers potential upside with high growth prospects despite current challenges.
Overview: HealthCare Global Enterprises Limited, along with its subsidiaries, offers medical and healthcare services with a focus on cancer and fertility both in India and internationally, and has a market cap of ₹64.78 billion.
Operations: The company's revenue primarily comes from setting up and managing hospitals and medical diagnostic services, totaling ₹19.77 billion.
Insider Ownership: 13.8%
HealthCare Global Enterprises is set to outpace the Indian market with forecasted revenue growth of 13.1% annually and earnings growth of 44.8%. Despite low return on equity expectations, the company's recent financials show robust performance, with Q2 sales reaching ₹5.52 billion and net income rising to ₹179.9 million from ₹135.7 million a year ago. Insider activity shows more buying than selling recently, though not in significant volumes, indicating cautious optimism among insiders amidst leadership changes.
Overview: Dalian Insulator Group Co., Ltd, with a market cap of CN¥4.53 billion, is involved in the research, development, manufacture, and sale of porcelain insulators both in China and internationally.
Operations: The company's revenue primarily comes from its activities in the research, development, manufacture, and sale of porcelain insulators both domestically and abroad.
Insider Ownership: 13%
Dalian Insulator Group is experiencing robust growth, with revenue expected to increase by 27.2% annually, surpassing the Chinese market's average. The company's earnings are projected to grow significantly at 33% per year, despite a low forecasted return on equity of 14.5%. Recent financials highlight strong performance; for the nine months ended September 2024, sales reached CNY 1.04 billion and net income rose sharply to CNY 155.54 million from CNY 38.68 million a year prior.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include IBSE:ODAS NSEI:HCG and SZSE:002606.
